Avadel Pharmaceuticals Plc Stock Price on April 29, 2024
| AVDL Stock | USD 15.95 0.19 1.21% |
Below is the normalized historical share price chart for Avadel Pharmaceuticals PLC extending back to June 07, 1996. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Avadel Pharmaceuticals stands at 15.95, as last reported on the 3rd of June, with the highest price reaching 16.00 and the lowest price hitting 15.57 during the day.
If you're considering investing in Avadel Stock, it is important to understand the factors that can impact its price. We consider Avadel Pharmaceuticals not too volatile. Avadel Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0185, which signifies that the company had a 0.0185% return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Avadel Pharmaceuticals PLC, which you can use to evaluate the volatility of the firm. Please confirm Avadel Pharmaceuticals' risk adjusted performance of 0.0834, and Mean Deviation of 2.27 to double-check if the risk estimate we provide is consistent with the expected return of 0.0496%.
At this time, Avadel Pharmaceuticals' Stock Based Compensation To Revenue is quite stable compared to the past year. . At this time, Avadel Pharmaceuticals' Price Fair Value is quite stable compared to the past year. Avadel Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 7th of June 1996 | 200 Day MA 13.9496 | 50 Day MA 16.8214 | Beta 1.632 |
Avadel |
Sharpe Ratio = 0.0185
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AVDL |
Estimated Market Risk
| 2.68 actual daily | 23 77% of assets are more volatile |
Expected Return
| 0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Avadel Pharmaceuticals is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Avadel Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 16.517 | Enterprise Value Ebitda (9.03) | Price Sales 51.7944 | Shares Float 95.4 M | Wall Street Target Price 23.65 |
Avadel Pharmaceuticals Main Headline on 29th of April 2024
Wall Street Analysts Predict a 28.58 percent Upside in Avade... by finance.yahoo.com
The average of price targets set by Wall Street analysts indicates a potential upside of 28.6 percent in Avadel . While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Avadel Pharmaceuticals Valuation on April 29, 2024
It is possible to determine the worth of Avadel Pharmaceuticals on a given historical date. On April 29, 2024 Avadel was worth 17.93 at the beginning of the trading date compared to the closed value of 17.97. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Avadel Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Avadel Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Avadel Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Avadel Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 17.85 | 18.22 | 17.71 | 17.81 | 452,421 | |
04/29/2024 | 17.93 | 18.26 | 17.82 | 17.97 | 553,917 |
| 17.90 | 18.65 | 17.85 | 18.16 | 849,696 |
| Backtest Avadel Pharmaceuticals | | | Avadel Pharmaceuticals History | | | Avadel Pharmaceuticals Valuation | Previous | Next |
Avadel Pharmaceuticals Trading Date Momentum on April 29, 2024
| On April 30 2024 Avadel Pharmaceuticals PLC was traded for 18.16 at the closing time. The top price for the day was 18.65 and the lowest listed price was 17.85 . The trading volume for the day was 849.7 K. The trading history from April 30, 2024 was a factor to the next trading day price upswing. The overall trading delta against the next closing price was 1.06% . The overall trading delta against the current closing price is 11.30% . |
Avadel Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Avadel Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Avadel Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Avadel financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Avadel Pharmaceuticals Stock history
Avadel Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Avadel is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Avadel Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Avadel Pharmaceuticals stock prices may prove useful in developing a viable investing in Avadel Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 80.2 M | 84.2 M | |
| Net Loss | -123.7 M | -117.5 M |
Avadel Pharmaceuticals Quarterly Net Working Capital |
|
Avadel Pharmaceuticals Stock Technical Analysis
Avadel Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Avadel Pharmaceuticals Period Price Range
Low | April 29, 2024
| High |
17.93 | 17.97 |
Avadel Pharmaceuticals June 3, 2024 Market Strength
Market strength indicators help investors to evaluate how Avadel Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Avadel Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Avadel Pharmaceuticals stock market strength indicators, traders can identify Avadel Pharmaceuticals PLC entry and exit signals to maximize returns
| Accumulation Distribution | 13347.4 | |||
| Daily Balance Of Power | 0.0909 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 18.04 | |||
| Day Typical Price | 18.02 | |||
| Price Action Indicator | (0.05) | |||
| Period Momentum Indicator | (2.02) |
Avadel Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Avadel Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Avadel Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Avadel to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0834 | |||
| Jensen Alpha | 0.3855 | |||
| Total Risk Alpha | 0.2143 | |||
| Sortino Ratio | 0.1384 | |||
| Treynor Ratio | 0.5358 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avadel Pharmaceuticals PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Avadel Pharmaceuticals information on this page should be used as a complementary analysis to other Avadel Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for Avadel Stock analysis
When running Avadel Pharmaceuticals' price analysis, check to measure Avadel Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avadel Pharmaceuticals is operating at the current time. Most of Avadel Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Avadel Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avadel Pharmaceuticals' price. Additionally, you may evaluate how the addition of Avadel Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
Is Avadel Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avadel Pharmaceuticals. If investors know Avadel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avadel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.82) | Revenue Per Share 0.633 | Quarterly Revenue Growth (1.00) | Return On Assets (0.55) | Return On Equity (7.80) |
The market value of Avadel Pharmaceuticals is measured differently than its book value, which is the value of Avadel that is recorded on the company's balance sheet. Investors also form their own opinion of Avadel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Avadel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avadel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Avadel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avadel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avadel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avadel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.